Trade Insight
    • Congress Trade
    • Insider Trade
    • Latest Trade
    • Congress Members
    • Corporate Insiders
More
  • TradeInsight.info LogoTradeInsight.info
      • FeaturesPricing
  • Sign InTry for Free
TradeInsight.info logo
TradeInsight.info
Formerly PelosiTrade.com
Operational
LinkedInGithubDiscord

Disclosures

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Product Updates

Knowledge

  • FAQ
  • Comparison guide
  • Security

Connect

  • About us
  • Contact
  • Careers

©2023-2025 TradeInsight.info. All rights reserved.

  • The content on this website is not intended as financial advice. Due diligence is required.
  • The date or time indicated here is given according to the US Eastern Time Zone.
  • The listed price is in USD and refers to the closing price on the specified trade date, before any adjustments due to stock splits or mergers, unless otherwise specified.
  • The Estimated Amount from Congress Trade is the midpoint of the trade value range from the report.
Cookie Notice

We use cookies to enhance your browsing experience.

Cookie Policy
  • 1/1
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.
Forgot your password?
Insider NameBuy/SellCompany NameTickerAmountShares Change
Mar 08, 2024Mar 13, 2024Brumm Joshua T
CEO
Pres
SellDyne Therapeutics, Inc.DYN$25.89$11M-44.41%
Mar 07, 2024Mar 12, 2024Brumm Joshua T
CEO
Pres
SellDyne Therapeutics, Inc.DYN$25.85$234,873-1.61%
Feb 29, 2024Mar 02, 2024Brumm Joshua T
CEO
Pres
SellDyne Therapeutics, Inc.DYN$28.96$3M-15.07%
Jan 03, 2024Jan 05, 2024Brumm Joshua T
CEO
Pres
SellDyne Therapeutics, Inc.DYN$18.66$5M-31.56%
Dec 11, 2023Dec 12, 2023Brumm Joshua TSellDyne Therapeutics, Inc.DYN$10.72$81,311-1.28%
Sep 18, 2023Sep 20, 2023Brumm Joshua TSellDyne Therapeutics, Inc.DYN$9.41$113,221-4.90%
Sep 12, 2023Sep 13, 2023Brumm Joshua TSellDyne Therapeutics, Inc.DYN$10.41$79,866-3.03%
Jun 08, 2023Jun 13, 2023Brumm Joshua TSellDyne Therapeutics, Inc.DYN$12.9$4M-56.22%
Mar 14, 2023Mar 15, 2023Brumm Joshua TSellDyne Therapeutics, Inc.DYN$13.33$97,549-2.22%
Dec 12, 2022Dec 13, 2022Brumm Joshua TSellDyne Therapeutics, Inc.DYN$10.87$36,110-1.00%
Oct 07, 2022Oct 11, 2022Brumm Joshua TSellDyne Therapeutics, Inc.DYN$12.52$3M-52.62%
Mar 11, 2022Mar 14, 2022Brumm Joshua TSellDyne Therapeutics, Inc.DYN$8.73$29,542-1.58%
Sep 20, 2021Sep 23, 2021Brumm Joshua TSellDyne Therapeutics, Inc.DYN$15.9$127,312-7.48%
Oct 19, 2017Oct 23, 2017Brumm Joshua T
COO
CFO
SellVersartis, Inc.VSAR$2.55$3,381-0.65%
Jun 13, 2017Jun 14, 2017Brumm Joshua T
COO
CFO
SellVersartis, Inc.VSAR$16.05$22,807-1.33%
May 16, 2017May 17, 2017Brumm Joshua T
COO
CFO
SellVersartis, Inc.VSAR$17.4$21,976-1.17%
Feb 24, 2017Mar 01, 2017Brumm Joshua T
COO
CFO
SellVersartis, Inc.VSAR$20.94$628,063-22.09%
Jan 30, 2017Feb 01, 2017Brumm Joshua T
COO
CFO
SellVersartis, Inc.VSAR$13.85$40,794-2.71%
Dec 27, 2016Dec 29, 2016Brumm Joshua T
CFO
SellVersartis, Inc.VSAR$15.85$15,692-1.50%
Dec 07, 2016Dec 08, 2016Brumm Joshua T
CFO
SellVersartis, Inc.VSAR$13.25$40,028-4.39%
Jun 15, 2016Jun 17, 2016Brumm Joshua T
CFO
SellVersartis, Inc.VSAR$10.63$15,392-2.40%
May 20, 2016May 20, 2016Brumm Joshua T
CFO
SellVersartis, Inc.VSAR$7.87$9,956-2.06%
Dec 30, 2015Jan 04, 2016Brumm Joshua T
CFO
SellVersartis, Inc.VSAR$12.44$12,312-2.71%
Nov 12, 2015Nov 13, 2015Brumm Joshua T
CFO
BuyVersartis, Inc.VSAR$9.99$24,975+6.40%